ClinicalTrials.gg
RecruitingNCT04332939Updated Mar 27, 2023

Motor System Activation With Transcranial Direct Current Stimulation and Physical Exercise to Reduce Pain in Elderly

An interventional study of transcranial direct current stimulation and Physical exercise in Chronic Pain, sponsored by Université de Sherbrooke. Recruiting at 2 sites in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-03-27.

Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2023, 3 years 1 month ago, but the record still lists the study as recruiting.
  • Started Dec 2020; still recruiting 5 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.

Planned enrollment
6th of 11
32 · median 32
Started
2020
with 1 other
No phase
10 of 15
7 open now
Registered
5th of 15
by date

Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the 6th largest by planned enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2020, is one of 10 with no phase, and was the 5th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Chronic Pain by Université de Sherbrooke, or all of them as a file.
02

Study summary

Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.

Read the detailed description

Prevalence and intensity of chronic pain increases substantially with age. According to several studies, physical exercises are effective to reduce chronic pain in elderly. However, it seems that exercises are not effective for everyone. One of the hypotheses raised is that the people in whom the exercises have no effect would be those with an alteration of the corticospinal tract. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique known to facilitate the corticospinal tract when applied over the motor cortex.

Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.

03

Conditions studied

  • Chronic Pain

Keywords

  • transcranial direct current stimulation
  • physical exercise
  • corticospinal projections
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To have musculoskeletal chronic pain
  • Not to change medication and life habits during the study

Exclusion criteria

Exclusion Criteria:

  • People physically active before the study (more then 150 min of moderate to vigorous exercise par week)
  • To have an uncontrolled cardiovascular disease
  • To have orthopedic limitation or to physical exercise
  • To have contraindication to tDCS
  • To have contraindication to TMS
  • To have contraindication to MRI
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Exercise + real tDCS

    Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).

    Other: transcranial direct current stimulation · Other: Physical exercise

  • Sham comparator
    Exercise + Sham tDCS

    Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of sham tDCS.

    Other: Physical exercise

Interventions

  • Othertranscranial direct current stimulation

    real tDCS sessions

  • OtherPhysical exercise

    Aerobic exercise and physical training combined with sham tDCS

06

What researchers measure

Primary outcomes

  1. Changes in Pain intensity

    Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10

    Time frame: Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)

Secondary outcomes

  1. Corticospinal excitability (TMS)

    Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS)

    Time frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after

  2. Corticospinal excitability (dMRI)

    Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging

    Time frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after

  3. Functional connectivity

    Functional connectivity will be assessed with functional magnetic resonance imaging

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  4. McGill pain questionnaire

    McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome.

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  5. Brief pain inventory

    Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  6. Beck depression inventory

    Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  7. Beck anxiety inventory

    Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  8. Margolis pain drawing and scoring system

    Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  9. Patient global impression of change questionnaire

    patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  10. Tampa questionnaire

    Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  11. Pain catastrophizing scale

    Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome

    Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

07

Study locations

2 of 2 sites recruiting
  • Research Centre on Aging
    Sherbrooke, Quebec J1H 4C4, Canada
    Recruiting
  • Grace Village
    Sherbrooke, Quebec J1M 0C6, Canada
    Recruiting
    • Guillaume Léonard, pht, PhD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2020 (actual). Primary completion is estimated for Oct 2023, 34 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 34 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2020
First posted
Apr 3, 2020
StartActual
Dec 1, 2020
Primary completionEst.
Oct 1, 2023
CompletionEst.
Dec 2024
Last update
Mar 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04332939
Responsible party
Guillaume Léonard (Professor, Université de Sherbrooke) — Principal investigator
First posted
Apr 3, 2020
Start date
Dec 1, 2020
Primary completion
Oct 1, 2023 (estimated)
Completion
Dec 2024 (estimated)
Last update
Mar 27, 2023

Study contacts

Guillaume Léonard, PhD. pht
Contact
guillaume.leonard2@usherbrooke.ca
1 819-780-2220 ext. 45246
Marie-Philippe HArvey, M.Sc
Contact
marie.philippe.harvey@usherbrooke.ca
1 819-780-2220 ext. 45156
Guillaume Léonard, pht, PhD.
principal investigator · Université de Sherbrooke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion